AR002069A1 - STABLE, CONCENTRATED AND LOCALLY COMPATIBLE ERYTHROMICILAMINE SOLUTIONS. - Google Patents
STABLE, CONCENTRATED AND LOCALLY COMPATIBLE ERYTHROMICILAMINE SOLUTIONS.Info
- Publication number
- AR002069A1 AR002069A1 ARP960102657A AR10265796A AR002069A1 AR 002069 A1 AR002069 A1 AR 002069A1 AR P960102657 A ARP960102657 A AR P960102657A AR 10265796 A AR10265796 A AR 10265796A AR 002069 A1 AR002069 A1 AR 002069A1
- Authority
- AR
- Argentina
- Prior art keywords
- stable
- solutions
- erythromicilamine
- concentrated
- erythromycylamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Una solución estable de eritromicilamina obtenida por disolución de la eritrocilamina en un medio acuoso tamponado a temperatura ambiente con valoresde pH entre 5 y 8 empleando preferentemente un sistema de tampón de fosfato. En estascondicione s la concentración de eritromicilamina puede estarcomprendida entre 5 y 40% en peso. La solución obtenida se esteriliza por filtración en condiciones asépticas. En estas condiciones las soluciones deeritromicilamina son estables ypueden emplea rse en medicina veterinaria en terapia e infecciones.A stable erythromycylamine solution obtained by dissolving erythrocylamine in a buffered aqueous medium at room temperature with pH values between 5 and 8, preferably using a phosphate buffer system. Under these conditions, the concentration of erythromycylamine can be between 5 and 40% by weight. The obtained solution is sterilized by filtration under aseptic conditions. Under these conditions, the erythromycylamine solutions are stable and can be used in veterinary medicine for therapy and infections.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19518917A DE19518917A1 (en) | 1995-05-23 | 1995-05-23 | Stable, concentrated, locally tolerated erythromycylamine solutions |
Publications (1)
Publication Number | Publication Date |
---|---|
AR002069A1 true AR002069A1 (en) | 1998-01-07 |
Family
ID=7762671
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP960102657A Withdrawn AR002069A1 (en) | 1995-05-23 | 1996-05-22 | STABLE, CONCENTRATED AND LOCALLY COMPATIBLE ERYTHROMICILAMINE SOLUTIONS. |
Country Status (6)
Country | Link |
---|---|
AR (1) | AR002069A1 (en) |
AU (1) | AU5898296A (en) |
DE (1) | DE19518917A1 (en) |
IL (1) | IL118381A0 (en) |
WO (1) | WO1996037190A1 (en) |
ZA (1) | ZA964082B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5723447A (en) * | 1996-07-02 | 1998-03-03 | Rhone Merieux, Inc. | Water miscible erythromycin solutions |
NZ523693A (en) * | 2000-07-10 | 2004-08-27 | Chiron Corp | Macrolide formulations for inhalation and methods of treatment of endobronchial infections |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA695765B (en) * | 1968-08-29 | 1971-03-31 | Lilly Co Eli | Erythromycylamine and process for preparing same |
ZA71763B (en) * | 1970-04-13 | 1972-03-29 | Lilly Industries Ltd | Erythromycylamines via hydrazones |
IL81395A0 (en) * | 1986-02-03 | 1987-08-31 | Lilly Co Eli | Novel derivatives of erythromycylamine |
US5110800A (en) * | 1986-02-18 | 1992-05-05 | Eli Lilly And Company | Derivatives of erythromycylamine |
DE4410637C1 (en) * | 1994-03-26 | 1995-09-21 | Boehringer Ingelheim Vetmed | Injectable solutions of dirithromycin |
-
1995
- 1995-05-23 DE DE19518917A patent/DE19518917A1/en not_active Withdrawn
-
1996
- 1996-05-17 AU AU58982/96A patent/AU5898296A/en not_active Abandoned
- 1996-05-17 WO PCT/EP1996/002117 patent/WO1996037190A1/en active Application Filing
- 1996-05-22 AR ARP960102657A patent/AR002069A1/en not_active Withdrawn
- 1996-05-22 ZA ZA964082A patent/ZA964082B/en unknown
- 1996-05-22 IL IL11838196A patent/IL118381A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL118381A0 (en) | 1996-09-12 |
DE19518917A1 (en) | 1996-11-28 |
ZA964082B (en) | 1996-11-22 |
WO1996037190A1 (en) | 1996-11-28 |
AU5898296A (en) | 1996-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE226085T1 (en) | PHARMACEUTICAL FORMULATIONS CONTAINING NERVE GROWTH FACTOR | |
DK0633721T3 (en) | Platelet purification with the 8-methoxypsoralen | |
ES2032563T3 (en) | A METHOD TO PRODUCE A FREEZE PHARMACEUTICAL COMPOSITION OF SMANCS. | |
IL86211A (en) | Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation | |
ES2037136T3 (en) | PROCEDURE FOR THE PREPARATION OF A SOLUTION WITH HIGH VOLUMETRIC ACTIVITY OF A PROTEIN WITH ACTIVITY OF TISSUE PLASMINOGEN ACTIVATOR (T-PA). | |
ES2162913T3 (en) | PHARMACEUTICAL PREPARATION CONTAINING PLASMINOGEN ACTIVATORS. | |
ES2194727T3 (en) | THREE-DIMENSIONAL STRUCTURES CONTAINING DERIVATIVES OF THE HIALURONIC ACID OBTAINED BY THE SUPERCRITICAL ANTIDISOLVENT TECHNIQUE. | |
AR002069A1 (en) | STABLE, CONCENTRATED AND LOCALLY COMPATIBLE ERYTHROMICILAMINE SOLUTIONS. | |
DE60043994D1 (en) | STABLE ACID FORMULATION OF INTERFERON, PREPARATION METHOD AND ITS USE | |
EP0200157A3 (en) | Use of an aqueous stabilized chlorite matrix solution in infectious conditions | |
ES2067520T3 (en) | ANTIBIOTICS AND PROCEDURE FOR ITS PRODUCTION. | |
HUP0302310A2 (en) | Novel formulations of alpha-2,4-disulfophenyl-n-tert-butylnitrone and process for their preparation | |
BR9611588A (en) | Use of flupirtine in the prophylaxis and therapy of diseases associated with damage to the hematopoietic cellular system | |
IT1226072B (en) | READY TO USE INJECTABLE SOLUTIONS CONTAINING AN ANTI-CYCLINIC ANTI-TUMORAL GLYCOSIDE. | |
RU2003122531A (en) | METHOD FOR CULTIVATION OF NITROFIXING BACTERIA | |
DK0402806T3 (en) | Crystalline cephemic acid addition salts and process for their preparation | |
ES2091764T3 (en) | WATER PURIFICATION SYSTEM. | |
ES2122962T3 (en) | OPTICALLY ACTIVE ALKYLENE-DIOXYBENZENE DERIVATIVES AND THEIR USE IN THERAPY. | |
RU97104339A (en) | DRUG "THEOTROPIN" FOR DISINFECTION OF OBJECTS OF SANITARY SURVEILLANCE | |
BRPI0411524A (en) | pharmaceutical formulation of amoxicillin and clavulanate, use of sodium carboxymethylcellulose, and method of treating bacterial infection in pediatric patients | |
DE69613803D1 (en) | Eye drops especially for the treatment of dry eyes | |
NO904120D0 (en) | PROTEIN-containing aqueous solutions. | |
DK15088D0 (en) | ANTIBACTERIAL LYOPHILIZED PREPARATION | |
ATE335494T1 (en) | USE OF N-GLYCOLNEURAMINE ACID AND DERIVATIVES THEREOF FOR PRODUCING A MEDICATION FOR THE TREATMENT OF HIV INFECTIONS | |
Trchounian et al. | On the reason of the principle of intramembrane interaction of transport systems in bacteria. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |